首页   按字顺浏览 期刊浏览 卷期浏览 Osteonecrosis in HIV: A Case-Control Study
Osteonecrosis in HIV: A Case-Control Study

 

作者: Anita Scribner,   Paolo Troia-Cancio,   Bruce Cox,   David Marcantonio,   Faruk Hamid,   Philip Keiser,   Marilyn Levi,   Brady Allen,   Kevin Murphy,   Richard Jones,   Daniel Skiest,  

 

期刊: JAIDS Journal of Acquired Immune Deficiency Syndromes  (OVID Available online 2000)
卷期: Volume 25, issue 1  

页码: 19-25

 

ISSN:1525-4135

 

年代: 2000

 

出版商: OVID

 

关键词: Avascular necrosis;Osteonecrosis;AIDS;HIV;Protease inhibitors

 

数据来源: OVID

 

摘要:

BackgroundOsteonecrosis (avascular necrosis) has been infrequently reported in HIV-infected patients. It is not known whether HIV itself is an independent risk factor for osteonecrosis.MethodsWe identified 25 patients with osteonecrosis from 1984 to 1999 from a large county teaching hospital and two large practices in Dallas County that specialize in HIV-disease related therapy. A retrospective chart review was performed to evaluate potential risk factors for osteonecrosis. Each case was matched with two controls for HIV positive status and date of osteonecrosis diagnosis.ResultsIn the study, 22 of 25 (88%) case patients had at least one osteonecrosis risk factor compared with 24 of 50 (48%) controls,p= .003. The most common osteonecrosis risk factors were hyperlipidemia (32%), alcoholism (28%), pancreatitis (16%), corticosteroids (12%), and hypercoaguability (12%). Of the cases, 12% were idiopathic. Multiple joints were involved in 72% of cases. Four of the case patients compared with none of the controls received megesterol acetate before the diagnosis of osteonecrosis,p= .01. No significant differences were found between cases and controls with respect to liver function tests, testosterone levels, triglyceride levels, cholesterol levels, or CD4 cell counts. Saquinavir was independently associated with osteonecrosis,p< .05. However, no differences in overall use of protease inhibitors among cases and controls were noted: 79% versus 76%, respectively.ConclusionsThe increased incidence of osteonecrosis in HIV/AIDS may be due to an increased frequency of risk factors previously associated with osteonecrosis such as hyperlipidemia, corticosteroid use, alcohol abuse, and hypercoaguability. Use of protease inhibitors was not independently associated with osteonecrosis.

 

点击下载:  PDF (70KB)



返 回